PL
PL · PL · PL-100477946
Skyrizi
ATC L04AC18
Last synced from URPL (Poland) on
Identification
ManufacturerAbbVie Deutschland GmbH & Co. KG
CountryPL (PL)
ATC codeL04AC18
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin08054083025186
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Roztwór do wstrzykiwań we wkładzie",
"source": "urpl",
"strength": "360 mg",
"packaging": "08054083025186 ¦ Rpz ¦ EU/1/19/1361/005 ¦ 148289\n1 wkład 2,4 ml + 1 osobisty aplikator do wstrzyknięcia podskórnego",
"substance": "Risankizumabum 150 mg/ml",
"common_name": "Risankizumabum",
"pl_product_id": "100477946",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L04AC18.
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
Access this data programmatically
Query Skyrizi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.